Trisha Gladd

ARTICLES BY TRISHA GLADD

• J&J Collaboration Explores Technology With Potential To Revolutionize Drug Development

  10/9/2015

  If the method used to determine whether or not a protein is a viable target for drug development were improved, pharmaceutical companies could potentially avoid the losses associated with finding out too late that a drug has harmful side effects and/or a lack efficacy. So how can pharma do this? Well, fortunately for them, some new technologies are now available to enhance their ability to select and evaluate safer targets in improved cell systems.

• Cell Thawing: Are You Risking GMP Compliance With The Water Bath Method?

  1/26/2015

  As we move into 2015, cell therapy as a viable and profitable market is becoming more of a reality, especially with the increased focus on unmet medical needs offering the potential for small companies to find their niche in the industry. However, one of the challenges with working with cells, at both the research and clinical level, is the issue of variability that can occur during the thawing of cryopreserved cells. Overcoming this challenge would address issues with current methods, such as viability, contamination, and inconsistent results.

• Three Ways A Logistics Partnership Can Reduce The Cost Of Global Expansion

  8/30/2013

  By Trisha Gladd, editor, Pharmaceutical Online and Bioprocess Online

  In order to meet the needs of an expanding global market, healthcare executives find themselves facing the daunting challenge of not only making their product accessible to foreign markets but also maintaining quality during shipment. I recently spoke with Robin Hooker, director of Global Healthcare Logistics Strategy at UPS, about how a logistics partnership can help reduce the costs associated with these challenges and provide advantages beyond the bottom line.